Osthole improves an accelerated focal segmental glomerulosclerosis model in the early stage by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-κB-mediated COX-2 expression and apoptosis-Reference-Cited by-同舟云学术

Osthole improves an accelerated focal segmental glomerulosclerosis model in the early stage by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-κB-mediated COX-2 expression and apoptosis

Published:2014-08 Issue: Volume:73 Page:260-269
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Yang Shun-Min,Chan Yi-Lin,Hua Kuo-Feng,Chang Jia-Ming,Chen Hui-Ling,Tsai Yung-Jen,Hsu Yu-Juei,Chao Louis Kuoping,Feng-Ling Yang,Tsai Yu-Ling,Wu Shih-Hsiung,Wang Yih-Fuh,Tsai Change-Ling,Chen Ann,Ka Shuk-Man

Funder

National Science Council

Medical Affairs Bureau

Tri-Service General Hospital

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference70 articles.

1. Focal segmental glomerulosclerosis;D׳Agati;N. Engl. J. Med.,2011

2. Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients;Kiffel;Adv. Chronic Kidney Dis.,2011

3. Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice;Rood;Nephrol. Dial. Transplant.,2012